OKYO · OKYO Pharma Ltd · Financials
Market Cap
$73.47M
Shares
52.48M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Diluted EPS
-$0.24
-100%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| $1.81M | $2.25M | $8.24M | $6.34M | $1.61M | $348.35K | $518.1K | |
| $1820 | $2563 | $3866 | $3797 | $2423 | $1512 | $212 | |
| $474.22K | $883.65K | $1.05M | $96.69K | — | $1123 | $1158 | |
| -$8.94M | -$7.97M | -$16.8M | -$13.28M | -$6.22M | -$3.38M | -$1.62M | |
| -$7987 | $3.26M | -$22.42K | $12.2K | $786.52K | $24.99K | $76.29K | |
| USD/shares | -$0.24 | -$0.12 | -$0.57 | -$0.61 | -$0.36 | -$0.32 | — |
| USD/shares | -$0.24 | -$0.12 | -$0.57 | -$0.61 | -$0.36 | -$0.32 | — |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.